“Helping Life Sciences companies safeguard their most valuable assets, particularly in the pharmaceutical and small-molecule space, is extremely rewarding and at the heart of my practice.
Shannon Reaney is the chair of the firm’s Patent Strategy + Prosecution Group and co-chair of the cross-disciplinary Intellectual Property Group. As a seasoned patent attorney, she provides strategic counsel to life sciences companies, specializing in developing and managing global patent portfolios.
With over 20 years of experience, Shannon excels in IP strategy for a wide range of life sciences technologies, including pre-clinical and clinical stage therapeutics, drug delivery systems and diagnostics. She has worked on numerous patent portfolios related to approved drugs and has helped innovator companies secure valuable patent term extension for a variety of approved drugs and biologics. Shannon has particular experience with small-molecule pharmaceuticals, siRNA therapeutics, peptide therapeutics, blood-based therapies, conjugates, pharmaceutical forms and formulations as well as agricultural technologies and materials.
MoFo Life Sciences Blog: Insights and Analyses on Industry Trends